title: Can the addition of bevacizumab to IFL chemotherapy improve outcome in colorectal cancer?
authors.affiliation: Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium. eric.vancutsem@uz.kuleuven.ac.be
authors.forename: Eric
authors.initials: E
authors.lastname: Van Cutsem